Tools that help developers to successfully deliver software

Software Configuration Management

Subscribe to Software Configuration Management: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Software Configuration Management: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn


SCM Authors: Stackify Blog, Elizabeth White, Mike Raia, John Basso, Derek Weeks

Related Topics: Software Configuration Management, Mergers & Acquisitions on Ulitzer

News Feed Item

Orthofix International Announces Release Date for Q209 Results

Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today announced that it will host a conference call and webcast on Thursday, July 30th, at 4:30 PM Eastern Time to discuss the Company’s results for the second quarter ended June 30, 2009, which will be released at approximately 4:00 PM that same day.

Interested parties may access the conference call by dialing (866) 626-7622 in the U.S. and Canada and (706) 758-3283 outside the U.S., and entering the conference ID 20357652. A replay of the call will be available for one week by dialing (800) 642-1687 in the U.S. and (706) 645-9291 outside the U.S., and entering the conference ID 20357652. A webcast of the conference call may be accessed by going to the company’s website at www.orthofix.com, by clicking on the Investors link and then the Events and Presentations page.

About Orthofix International, N.V.

Orthofix International N.V., a global medical device company, offers a broad line of minimally invasive surgical, as well as non-surgical, products for the spine, orthopedic, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages, helping them achieve a more active and mobile lifestyle. Orthofix’s products are widely distributed around the world to orthopedic surgeons, hospitals and patients via Orthofix’s sales representatives and its subsidiaries, including Breg, Inc. and Blackstone Medical, Inc. In addition, Orthofix is collaborating in R&D partnerships with leading institutions such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, the Musculoskeletal Transplant Foundation, and the National Osteoporosis Institute. For more information about Orthofix, please visit www.orthofix.com.

Forward-Looking Statements

This communication contains certain forward-looking statements under the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which may include, but are not limited to, statements concerning the projections, financial condition, results of operations and businesses of Orthofix and its subsidiaries and are based on management’s current expectations and estimates and involve risks and uncertainties that could cause actual results or outcomes to differ materially from those contemplated by the forward-looking statements.

Factors that could cause or contribute to such differences may include, but are not limited to, risks relating to the expected sales of its products, including recently launched products, unanticipated expenditures, changing relationships with customers, suppliers and strategic partners, risks relating to the protection of intellectual property, changes to the reimbursement policies of third parties, changes to and interpretation of governmental regulation of medical devices, the impact of competitive products, changes to the competitive environment, the acceptance of new products in the market, conditions of the orthopedic industry and the economy, corporate development and market development activities, including acquisitions or divestitures, unexpected costs or operating unit performance related to recent acquisitions and other factors described in our annual report on Form 10-K and other periodic reports filed by the Company with the Securities and Exchange Commission.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.